TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency April 19, 1996
TCL Archive Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million. December 9, 2005
